| scholarly article | Q13442814 |
| P2093 | author name string | Jung-Joon Min | |
| Yeongjin Hong | |||
| Hyon E Choy | |||
| Dong-Yeon Kim | |||
| Michael Szardenings | |||
| Seung-Hwan Park | |||
| Jin Hai Zheng | |||
| Vu Hong Nguyen | |||
| Jung Hyun Min | |||
| Sheng-Nan Jiang | |||
| P2860 | cites work | Solution structures and integrin binding activities of an RGD peptide with two isomers | Q27631496 |
| One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products | Q27860842 | ||
| Display of polyhistidine peptides on the Escherichia coli cell surface by using outer membrane protein C as an anchoring motif | Q30804768 | ||
| Microbial cell-surface display | Q31121268 | ||
| Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma | Q33340438 | ||
| Consensus guided mutagenesis of Renilla luciferase yields enhanced stability and light output | Q34549716 | ||
| Pancreatic cancer regression by intratumoural injection of live Streptococcus pyogenes in a syngeneic mouse model. | Q34585120 | ||
| A molecular Swiss army knife: OmpA structure, function and expression | Q34636047 | ||
| Targeted therapy of spinal cord glioma with a genetically modified Salmonella typhimurium | Q34988082 | ||
| Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer | Q35840470 | ||
| Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β. | Q36191597 | ||
| Engineering the perfect (bacterial) cancer therapy | Q37131536 | ||
| Engineering of bacteria for the visualization of targeted delivery of a cytolytic anticancer agent | Q37316867 | ||
| Bacteriolytic therapy can generate a potent immune response against experimental tumors | Q37585498 | ||
| Salmonella engineered to express CD20-targeting antibodies and a drug-converting enzyme can eradicate human lymphomas. | Q39143931 | ||
| Engineering of Escherichia coli for targeted delivery of transgenes to HER2/neu-positive tumor cells | Q39588838 | ||
| Genetically engineered Salmonella typhimurium as an imageable therapeutic probe for cancer | Q39760012 | ||
| Efficacy of a genetically-modified Salmonella typhimurium in an orthotopic human pancreatic cancer in nude mice. | Q39837601 | ||
| Attenuated Salmonella targets prodrug activating enzyme carboxypeptidase G2 to mouse melanoma and human breast and colon carcinomas for effective suicide gene therapy | Q39966345 | ||
| Integrin-targeted imaging and therapy with RGD4C-TNF fusion protein | Q39981826 | ||
| Salmonella choleraesuis as an anticancer agent in a syngeneic model of orthotopic hepatocellular carcinoma. | Q40062398 | ||
| ppGpp-dependent stationary phase induction of genes on Salmonella pathogenicity island 1. | Q40552048 | ||
| Bacterial surface display of an anti-pollutant antibody fragment | Q40811552 | ||
| Activation of inflammasome by attenuated Salmonella typhimurium in bacteria-mediated cancer therapy | Q40937873 | ||
| Functional expression of adhesive peptides as fusions to Escherichia coli flagellin | Q41486491 | ||
| Surface-displayed viral antigens on Salmonella carrier vaccine. | Q42998832 | ||
| ppGpp-mediated stationary phase induction of the genes encoded by horizontally acquired pathogenicity islands and cob/pdu locus in Salmonella enterica serovar Typhimurium | Q43134134 | ||
| Continuous intravenous administration of live genetically modified salmonella typhimurium in patients with metastatic melanoma | Q43161957 | ||
| Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice | Q43677697 | ||
| Arginine-glycine-aspartic acid (RGD)-peptide binds to both tumor and tumor-endothelial cells in vivo | Q44138557 | ||
| Antitumour activity of Salmonella typhimurium VNP20047 in B16(F10) murine melanoma model. | Q45078427 | ||
| Quantitative bioluminescence imaging of tumor-targeting bacteria in living animals | Q47794539 | ||
| Intratumoral delivery and suppression of prostate tumor growth by attenuated Salmonella enterica serovar typhimurium carrying plasmid-based small interfering RNAs | Q50071115 | ||
| Attenuated Salmonella typhimurium invades and decreases tumor burden in neuroblastoma | Q50089382 | ||
| Tumor-targeted Salmonella as a novel anticancer vector | Q50133173 | ||
| A genetic system to elicit and monitor antipeptide antibodies without peptide synthesis. | Q54701470 | ||
| Bacteria-mediated delivery of nanoparticles and cargo into cells | Q58620700 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 1672-1682 | |
| P577 | publication date | 2016-06-20 | |
| P1433 | published in | Theranostics | Q21051383 |
| P1476 | title | RGD Peptide Cell-Surface Display Enhances the Targeting and Therapeutic Efficacy of Attenuated Salmonella-mediated Cancer Therapy | |
| P478 | volume | 6 |
| Q52568531 | A microfluidic device for studying chemotaxis mechanism of bacterial cancer targeting. |
| Q47695533 | Anticancer Efficacy of Targeted Shikonin Liposomes Modified with RGD in Breast Cancer Cells. |
| Q90571102 | Awakening p53 in vivo by D-peptides-functionalized ultra-small nanoparticles: Overcoming biological barriers to D-peptide drug delivery |
| Q91890842 | Bacteria-cancer interactions: bacteria-based cancer therapy |
| Q89992810 | Design of Outer Membrane Vesicles as Cancer Vaccines: A New Toolkit for Cancer Therapy |
| Q57181833 | Dotted Core-Shell Nanoparticles for T -Weighted MRI of Tumors |
| Q33836407 | Drug-Bearing Supramolecular Filament Hydrogels as Anti-Inflammatory Agents |
| Q54213329 | Endostatin gene therapy delivered by attenuated Salmonella typhimurium in murine tumor models. |
| Q92063552 | Imaging of tumor colonization by Escherichia coli using 18F-FDS PET |
| Q88555639 | PEP06 polypeptide 30 exerts antitumour effect in colorectal carcinoma via inhibiting epithelial-mesenchymal transition |
| Q47868574 | PET and SPECT imaging of melanoma: the state of the art. |
| Q33798724 | Salmonella mediated the hemagglutinating virus of Japan-envelope transfer suppresses tumor growth |
| Q91743156 | Salmonella-Based Targeted Cancer Therapy: Updates on A Promising and Innovative Tumor Immunotherapeutic Strategy |
| Q28069354 | Targeted Cancer Therapy Using Engineered Salmonella typhimurium |
| Q58599910 | Tumour-targeting bacteria engineered to fight cancer |
| Q104280671 | Tweak to Treat: Reprograming Bacteria for Cancer Treatment |
Search more.